M2MC
LLY icon

Matthew 25 Management Corp’s Eli Lilly LLY Stock Holding History

Matthew 25 Management Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3M Buy
27,500
+2,000
+8% +$2.03M 8.4% 3
2025
Q4 		$27.4M Buy
25,500
+10,000
+65% +$9.56M 8.38% 4
2025
Q3 		$11.8M Buy
15,500
+8,250
+114% +$6.14M 3.64% 13
2025
Q2 		$5.65M Buy
+7,250
New +$5.63M 1.82% 17

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Matthew 25 Management Corp's LLY Position: Q1 2026 in Review

Matthew 25 Management Corp increased its Eli Lilly (LLY) stake by 7.8% in Q1 2026, buying an estimated $2.03M and bringing the position to 27,500 shares worth $25.3M. The position accounts for 8.4% of the portfolio, ranked #3.

Matthew 25 Management Corp first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $27.4M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Matthew 25 Management Corp held 27,500 shares of Eli Lilly worth $25.3M as of Q1 2026.
  • Matthew 25 Management Corp bought 2,000 Eli Lilly shares in Q1 2026, an estimated $2.03M.
  • Eli Lilly made up 8.4% of Matthew 25 Management Corp's portfolio in Q1 2026, its #3 holding.
  • Matthew 25 Management Corp first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Matthew 25 Management Corp's Eli Lilly position peaked at $27.4M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Matthew 25 Management Corp's 13F filing for Q1 2026, filed 12 May 2026.